Ledger.Open graph →
SEC Form D · filed October 2, 2015

Antegrin Therapeutics, Inc

Offering
$600K
Sold
$100K
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
ST. LOUIS, MO
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (20)

David W. Griggs · St. Louis, MODirectorDiego D. De La Torre De La Piedra · Vancouver, British Columbia, CanadaDirectorBrian J. Maher · Vancouver, British Columbia, CanadaDirectorJonathan Rigby · San Ramon, CADirectorJorge D. Benavides Alfaro · Vancouver, British Columbia, CanadaExec · DirectorJames C. Stretz · Denver, COExecElizabeth W. Cermak · San Ramon, CADirectorWilliam C. Perkins · Madison, WIExec · DirectorMichael J. Taylor · Solon, OHDirectorThomas P. Cirrito · St. Louis, MODirectorDonald W. Huffman · San Ramon, CADirectorCharles A. Bolten · St. Louis, MODirectorGeorge H. Capps, Ii · St. Louis, MOExecMichael W. Yeadon · St. Louis, MODirectorJames L. Logue, Iii · Lansing, MIDirectorRajesh J. Devraj · St. Louis, MODirectorBrian D. Imrie · Vancouver, British Columbia, CanadaDirectorPaul Wozniak · San Francisco, CAExecScott D. Macdonald · Toronto, Ontario, CanadaDirectorRobert W. Karr · St. Louis, MOExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗